Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.
Standard
Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. / Schäfer, Ellen; Baron, Karin; Widmer, Urs; Deegan, Patrick; Neumann, Hartmut P H; Sunder-Plassmann, Gere; Johansson, Jan-Ove; Whybra, Catharina; Ries, Markus; Pastores, Gregory M; Mehta, Atul; Beck, Michael; Gal, Andreas.
in: HUM MUTAT, Jahrgang 25, Nr. 4, 4, 2005, S. 412.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.
AU - Schäfer, Ellen
AU - Baron, Karin
AU - Widmer, Urs
AU - Deegan, Patrick
AU - Neumann, Hartmut P H
AU - Sunder-Plassmann, Gere
AU - Johansson, Jan-Ove
AU - Whybra, Catharina
AU - Ries, Markus
AU - Pastores, Gregory M
AU - Mehta, Atul
AU - Beck, Michael
AU - Gal, Andreas
PY - 2005
Y1 - 2005
N2 - Fabry disease (FD) is an X-chromosomal disorder caused by mutations in the GLA gene encoding the lysosomal enzyme alpha-galactosidase A. We performed mutation screening on a cohort of 121 patients including 84 male and 37 female index cases and identified a total of 90 different mutations, 34 of which are reported for the first time here. Both point mutations (74.4%) and 'short length' rearrangements (25.6%) were found, including missense (54.4%), nonsense (14.4%), and splice site point mutations (5.6%), deletions (17.8%) or insertions/duplications (5.6%) of a few nucleotides, and complex rearrangements including larger deletions (2.2%). GLA mutations were identified in 82 (97.6%) of the 84 unrelated male patients.
AB - Fabry disease (FD) is an X-chromosomal disorder caused by mutations in the GLA gene encoding the lysosomal enzyme alpha-galactosidase A. We performed mutation screening on a cohort of 121 patients including 84 male and 37 female index cases and identified a total of 90 different mutations, 34 of which are reported for the first time here. Both point mutations (74.4%) and 'short length' rearrangements (25.6%) were found, including missense (54.4%), nonsense (14.4%), and splice site point mutations (5.6%), deletions (17.8%) or insertions/duplications (5.6%) of a few nucleotides, and complex rearrangements including larger deletions (2.2%). GLA mutations were identified in 82 (97.6%) of the 84 unrelated male patients.
M3 - SCORING: Zeitschriftenaufsatz
VL - 25
SP - 412
JO - HUM MUTAT
JF - HUM MUTAT
SN - 1059-7794
IS - 4
M1 - 4
ER -